Methods and reagents are disclosed for enhancing the bioavailability of a hydrophobic drug, and in some embodiments for determining a hydrophobic drug, in a sample suspected of containing a hydrophobic drug. A combination is formed in a medium where the combination comprises the sample, a hemolytic agent where a determination of the hydrophobic drug is conducted, and a bioavailability agent for the hydrophobic drug. The bioavailability agent comprises an ionic detergent comprising a chain of at least 10 carbon atoms or a non-ionic detergent comprising a chain of at least 15 repeating ethylene oxide units or propylene oxide units or a combination of ethylene oxide units and propylene oxide units. The concentration of the bioavailability agent in the medium is sufficient to enhance the bioavailability of the hydrophobic drug. The medium is incubated under conditions for enhancing the bioavailability of the hydrophobic drug, and in a determination of the hydrophobic drug under conditions for hemolyzing cells in the sample. For determination of the hydrophobic drug, reagents for determining the presence and/or amount of the hydrophobic drug in the sample are added to the medium. The reagents comprise at least one antibody for the hydrophobic drug. The medium is examined for the presence of a complex comprising the hydrophobic drug and the antibody for the hydrophobic drug. The presence and/or amount of the complex indicates the presence and/or amount of the hydrophobic drug in the sample.
本文披露了一种增强疏
水药物
生物利用度的方法和试剂,并在某些实施例中用于确定疏
水药物在疑似含有疏
水药物的样品中的存在。在介质中形成一种组合物,其中组合物包括样品、溶血剂(用于对疏
水药物进行测定)和疏
水药物的
生物利用度剂。
生物利用度剂包括至少10个碳原子链的离子性洗涤剂或至少15个重复的乙氧基单元或丙氧基单元的非离子性洗涤剂或乙氧基单元和丙氧基单元的组合物。介质中
生物利用度剂的浓度足以增强疏
水药物的
生物利用度。在增强疏
水药物的
生物利用度条件下孵育介质,并在 hemolyzing 细胞的条件下对疏
水药物进行测定。对于疏
水药物的测定,向介质中添加用于确定样品中疏
水药物存在和/或数量的试剂。试剂包括至少一种疏
水药物的
抗体。检查介质中是否存在包括疏
水药物和疏
水药物
抗体的复合物。复合物的存在和/或数量表明样品中存在和/或数量的疏
水药物。